Chemi-Luminescence ImmunoAssay (CLIA) for the Qualitative/Quantitative determination of Hepatitis CORE surface Antigen Total Antibodies or HBcAb in human plasma and sera. The kit is intended for the screening of blood units and the follow-up of HBV-infected patients. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the qualitative determination of antibodies to Trypanosoma cruzi (Tc) in human plasma and sera. The kit is intended for the screening of blood units and the follow-up of Tc-infected patients. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the qualitative determination of antibodies (IgG, IgM and IgA) to Treponema Pallidum. The kit may be used for the screening of blood units and the follow-up of Tp-infected patients.

Chemi-Luminescence ImmunoAssay (CLIA) for the determination of antibodies to Hepatitis C Virus in human plasma and sera. The kit may be used for the screening of blood units and the follow-up of HCV-infected patients. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the determination of antibodies to T-cell Lymphotropic Virus type I&II in human plasma and sera. The kit may be used for the screening of blood units and the follow-up of HTLV I&II-infected patients, not for typing HTLV I&II. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the quantitative determination of Hepatitis B surface Antigen or HBsAg in human plasma and sera. The kit may be used for the screening of blood units, is able to detect HBsAg mutants and find application in the follow-up of HBV-infected patients. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.

Chemi-Luminescence ImmunoAssay (CLIA) for the diagnostic screening of antibodies to all subtypes of HIV-1 and HIV-2 and HIV-1 antigen (p24) in human serum or plasma and the follow up of HIV- infected patients. This kit is intended exclusively for In vitro diagnostic use in an authorized clinical laboratory and the test has to be carried out by specifically trained health-care professional personnel. The device has been adapted for the use in exclusive combination with the Dia.Pro instrument named SARA.